Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 289, Issue 3 52-3, 2005, Pages

  Cheng, Ling ^a   Cao, Weibiao ^a   Fiocchi, Claudio ^b   Behar, Jose ^a   Biancani, Piero ^a   Harnett, Karen M ^a,c  

^a BROWN UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Inflammation; Reactive oxygen species; Smooth muscle contraction

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; ACETYLCHOLINE; HYDROGEN PEROXIDE; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROTRANSMITTER; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ELECTROSTIMULATION; ESOPHAGITIS; ESOPHAGUS MUSCLE; INFLAMMATION; MALE; MOTOR DYSFUNCTION; MUSCLE CONTRACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; CATS; DINOPROSTONE; ESOPHAGITIS; ESOPHAGUS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PLATELET ACTIVATING FACTOR; REACTIVE OXYGEN SPECIES;

EID: 24044518156     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00024.2005     Document Type: Article

References (74)

1. Alonso F, Gil MG, Sanchez-Crespo M, and Mato JM. Activation of 1-alkyl-2-lysoglycero-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J Biol Chem 257: 3376-3378, 1982.
2. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, and Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97: 2672-2679, 1996.
3. Balboa MA, Varela-Nieto I, Killermann Lucas K, and Dennis EA. Expression and function of phospholipase A(2) in brain. FEBS Lett 531: 12-17, 2002.
4. Beani L, Bianchi C, Siniscalchi A, Sivilotti L, Tanganelli S, and Veratti E. Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux. Naunyn Schmiedebergs Arch Pharmacol 328: 119-126, 1984.
5. Behar J, Guenard V, Walsh JH, and Biancani P. VIP and acetylcholine: neurotransmitters in esophageal circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 257: G380-G385, 1989.
6. Biancani P, Berwick K, Selling J, and McCallum R. Effects of acute experimental esophagitis in mechanical properties of the lower esophageal sphincter. Gastroenterotogy 87: 8-16, 1984.
7. Biancani P, Zabinski M, Kerstein M, and Behar J. Lower esophageal sphincter mechanics: anatomic and physiologic relationships of the esophagogastric junction of the cat. Gastroenterology 82: 468-475, 1982.
8. Blennerhassett MG, Vignjevic P, Vermillion DL, and Collins SM. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. Am J Physiol Gastrointest Liver Physiol 262: G1041-G1046, 1992.
9. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
10. Boulanger MJ, Bankovich AJ, Kortemme T, Baker D, and Garcia KC. Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell 12: 577-589, 2003.
11. Camussi G, Tetta C, Bussolino F, Andres G, Turello E, and Baglioni C. Involvement of cytokines and platelet-activating factor in renal pathology. J Lipid Mediat 2, Suppl: S203-S213, 1990.
12. Cao W, Cheng L, Behar J, Fiocchi C, Biancani P, and Harnett KM. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol 287: G1131-G1139, 2004.
13. Cao WB, Harnett KM, Chen Q, Jain MK, Behar J, and Biancani P. Group I secreted PLA2 (sPLA2) and arachidonic acid metabolites in the maintenance of cat LES tone. Am J Physiol Gastrointest Liver Physiol 277: G585-G598, 1999.
14. Cheng JT and Shinozuka K. Prostaglandin E2 induced the cyclic AMP-dependent release of acetylcholine in circular muscles of the isolated guinea pig ileum. Neurosci Lett 83: 293-297, 1987.
15. Cheng L, Cao W, Behar J, Biancani P, and Harnett KM. Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am J Physiol Gastrointest Liver Physiol 288: G787-G797, 2005.
16. Clarke DL, Giembycz MA, Patel HJ, and Belvisi MG. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol 141: 600-609, 2004.
17. Collins S, Blennerhassett P, Blennerhassett M, and Vermillion D. Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol Gastrointest Liver Physiol 257: G898-G903, 1989.
18. Collins S, Blennerhassett P, Vermillion D, Davis K, Langer J, and Ernst P. Impaired acetylcholine release in the inflamed rat intestine is T cell independent. Am J Physiol Gastrointest Liver Physiol 263: G198-G201, 1992.
19. Collins S, Hurst S, Main C, Stanley E, Khan I, Blennerhassett P, and Swain M. Effect of inflammation of enteric nerves. Cytokine-induced changes in neurotransmitter content and release. Ann NY Acad Sci 664: 415-424, 1992.
20. D'Agostino G, Bolognesi ML, Lucchelli A, Vicini D, Balestra B, Spelta V, Melchiorre C, and Tonini M. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol 129: 493-500, 2000.
21. 3H]acetylcholine release in the rat urinary bladder. J Pharmacol Exp Ther 239: 522-528, 1986.
22. DeLisle S, Biggs D, Wang A, and Martin JG. Effects of prostaglandin E2 on ganglionic transmission in the guinea pig trachea. Respir Physiol 87: 131-139, 1992.
23. Dieterich HA, Kaffel H, Kilbinger H, and Loffelholz K. The effects of physostigmine on cholinesterase activity, storage and release of acetylcholine in the isolated chicken heart. J Pharmacol Exp Ther 199: 236-246, 1976.
24. Eastwood GL, Castell DO, and Higgs RH. Experimental esophagitis in cats impairs lower esophageal sphincter pressure. Gastroenterology 69: 146-153, 1976.
25. Feuerstein TJ, Lehmann J, Sauermann W, van Velthoven V, and Jackisch R. The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res 572: 64-71, 1992.
26. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
27. Galeazzi F, Haapala EM, van Rooijen N, Vallance BA, and Collins SM. Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol 278: G259-G265, 2000.
28. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, and Zhang D. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68: 4628-4635, 1994.
29. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, and Prescott SM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96: 2322-2330, 1995.
30. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
31. Hinson RM, Williams JA, and Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 93: 4885-4890, 1996.
32. Howells GL. Cytokine networks in destructive periodontal disease. Oral Dis 1: 266-270, 1995.
33. 2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274: 1776-1782, 1999.
34. Hurst SM and Collins SM. Mechanism underlying tumor necrosis factor-α suppression of norepinephrine release from rat myenteric plexus. Am J Physiol Gastrointest Liver Physiol 266: G1123-G1129, 1994.
35. Ito I, Suzuki H, Aizawa H, Hirose T, and Hakoda H. Pre-junctional inhibitory action of prostaglandin E2 on excitatory neuro-effector transmission in the human bronchus. Prostaglandins 39: 639-655, 1990.
36. James MK and Cubeddu LX. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum. J Pharmacol Exp Ther 229: 98-104, 1984.
37. Kadlec O, Masek K, and Seferna I. Modulation by prostaglandins of the release of acetylcholine and noradrenaline in guinea-pig isolated ileum. J Pharmacol Exp Ther 205: 635-645, 1978.
38. Kaur J, Dhaunsi GS, and Turner RB. Interleukin-1 and nitric oxide increase NADPH oxidase activity in human coronary artery smooth muscle cells. Med Pr 13: 26-29, 2004.
39. Komatsu H, Yaju H, Chiba K, and Okumoto T. Inhibition of cyclooxygenase inhibitors of interleukin-6 production by human peripheral blood mononuclear cells. Int J Immunopharmacol 13: 1137-1146, 1991.
40. 2 generation in rat 3Y1 fibroblasts. J Biol Chem 273: 1733-1740, 1998.
41. Leisten JC, Gaarde WA, and Scholz W. Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin. Clin Immonol Immunopathol 56: 108-115, 1990.
42. Maier JA, Hla T, and Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 265: 10805-10808, 1990.
43. Main C, Blennerhassett P, and Collins SM. Human recombinant interleukin 1 beta suppresses acetylcholine release from rat myenteric plexus. Gastroenterology 104: 1648-1654, 1993.
44. Martin MU and Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592: 265-280, 2002.
45. McIntyre TM, Zimmerman GA, and Prescott SM. Biologically active oxidized phospholipids. J Biol Chem 274: 25189-25192, 1999.
46. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, and Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263: 539-545, 1989.
47. Mendes AF, Caramona MM, Carvalho AP, and Lopes MC. Hydrogen peroxide mediates interleukin-1beta-induced AP-1 activation in articular chondrocytes: implications for the regulation of iNOS expression. Cell Biol Toxicol 19: 203-214, 2003.
48. Morrow JD and Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1-21, 1997.
49. Mulholland MW and Simeone DM. Prostaglandin E2 stimulation of acetylcholine release from guinea pig myenteric plexus neurons. Am J Surg 166: 552-556, 1993.
50. Muller MJ, Huizinga JD, and Collins SM. Altered smooth muscle contraction and sodium pump activity in the inflamed rat intestine. Am J Physiol Gastrointest Liver Physiol 257: G570-G577, 1989.
51. Nakanishi H, Yoshida H, and Suzuki T. Inhibitory effects of prostaglandin E1 and E2 on cholinergic transmission in isolated canine tracheal muscle. Jpn J Pharmacol 26: 669-674, 1976.
52. Negishi M, Sugimoto Y, and Ichikawa A. Prostanoid receptors and their biological actions. Prog Lipid Res 32: 417-434, 1993.
53. Ogle CK, Guo X, Szczur K, Hartmann S, and Ogle JD. Production of tumor necrosis factor, interleukin-6 and prostaglandin E2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin. Inflammation 18: 175-185, 1994.
54. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, and Isakson PC. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 184: 883-891, 1996.
55. 3H] acetylcholine release from isolated human bronchi. Br J Pharmacol 125: 271-276, 1998.
56. Renooij W and Snyder F. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3- phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Biochim Biophys Acta 663: 545-556, 1981.
57. Rieder F, Phillips H, West GA, Chak A, Cooper G, Isenberg G, Ray M, Katz J, Wong R, Post A, O'Shea R, Sivak M, Biancani P, and Fiocchi C. Production of the pro-inflammatory cytokines IL-1β, IL-6 and IL-8 in active esophagitis (Abstract). Gastroenterology 122: A-420, 2002.
58. Shore S, Collier B, and Martin JG. Effect of endogenous prostaglandins on acetylcholine release from dog trachealis muscle. J Appl Physiol 62: 1837-1844, 1987.
59. Smiley PL, Stremler KE, Prescott SM, Zimmerman GA, and McIntyre TM. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem 266: 11104-11110, 1991.
60. Spicuzza L, Giembycz MA, Barnes PJ, and Belvisi MG. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype. Br J Pharmacol 123: 1246-1252, 1998.
61. Szerb JC. Endogenous acetylcholine release and labelled acetylcholine formation from [3H]choline in the myenteric plexus of the guinea-pig ileum. Can J Physiol Pharmacol 53: 566-574, 1975.
62. Tanaka T, Iimori M, Tsukatani H, and Tokumura A. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. Biochim Biophys Acta 1210: 202-208, 1994.
63. Teather LA, Lee RK, and Wurtman RJ. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. Brain Res 946: 87-95, 2002.
64. Teitelbaum DH, O'Dorisio TM, Perkins WE, and Gaginella TS. Somatostatin modulation of peptide-induced acetylcholine release in guinea pig ileum. Am J Physiol Gastrointest Liver Physiol 246: G509-G514, 1984.
65. Testylier G and Dykes RW. Acetylcholine release from frontal cortex in the waking rat measured by microdialysis without acetylcholinesterase inhibitors: effects of diisopropylfluorophosphate. Brain Res 740: 307-315, 1996.
66. Tiku ML, Liesch JB, and Robertson FM. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 145: 690-696, 1990.
67. Tolando R, Jovanovic A, Brigelius-Flohe R, Ursini F, and Maiorino M. Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: effect of selenium supplementation. Free Radic Biol Med 28: 979-986, 2000.
68. Van Assche G, Barbara G, Deng Y, Lovato P, Gauldie J, and Collins SM. Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. Gastroenterology 116: 346-353, 1999.
69. Vermillion DL and Collins SM. Increased responsiveness of jejunal longitudinal muscle in Trichinella-infected rats. Am J Physiol Gastrointest Liver Physiol 254: G124-G129, 1988.
70. Vermillion DL, Ernst PB, and Collins SM. T-lymphocyte modulation of intestinal muscle function in the Trichinella-infected rat. Gastroenterology 101: 31-38, 1991.
71. Wang HY, Yue TL, Feuerstein G, and Friedman E. Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. J Neurochem 63: 1720-1725, 1994.
72. 72a. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M, and Nickenig G. Interleukin-6 induces oxiative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94: 534-541, 2004.
73. Williams JA and Shacter E. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem 272: 25693-25699, 1997.
74. Zhao WW, Robinson NE, and Yu MF. PGE2 inhibits acetylcholine release from cholinergic nerves in canine but not equine airways. Prostaglandins Leukot Essent Fatty Acids 51: 347-355, 1994.